{"name":"Kastle Therapeutics, LLC","slug":"kastle-therapeutics-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ISIS 301012","genericName":"ISIS 301012","slug":"isis-301012","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"ISIS 301012","genericName":"ISIS 301012","slug":"isis-301012","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxNR0pBY3RBaWNMd1pGQ1ZQNnd6TWNkdUFiSmFTQVhDby1fQXpLLUZ2dURpSXZjUlZsQW1sVWtkUldjNmVBcnlwZ1BoOTN0NlFqZmlLcGRTYm1qUzluaWZ1bERySWE0UjJ1M3dKeDF2UG92V0djRWhKajVkenk0N2pmSkxDVGFFNzYxSlU0aXhNd3lYQ09uMWhlcXAzb2FGU3B5T1BFVFNVQzdlSVNuTEJOOTFmVmtXcmRlX2dQN2FMZXVlNjJiMGt4Q0lFdHZ2cXdYeElhRkNWdG4yd29fVW0zX2E0NWNoTnNXdWdFMkF3?oc=5","date":"2015-07-30","type":"deal","source":"PR Newswire","summary":"Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics - PR Newswire","headline":"Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}